Skip to Content
Merck
CN

1708784

USP

Valsartan Related Compound B

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

N-(1-Oxobutyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine, (S)-N-Butyryl-N-{[2′-(1-H-tetrazole-5-yl)-biphenyl-4-yl]methyl}valine

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C23H27N5O3
CAS Number:
952652-79-8
Molecular Weight:
421.49
NACRES:
NA.24
PubChem Substance ID:
329751481
UNSPSC Code:
41116107
MDL number:
MFCD19689078

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1

SMILES string

CCCC(=O)N(Cc1ccc(cc1)-c2ccccc2-c3nnn[nH]3)[C@@H](C(C)C)C(O)=O

InChI key

OKAQHVJSXLGXET-NRFANRHFSA-N

grade

pharmaceutical primary standard

API family

valsartan

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

This USP reference standard is intended for use in specified quality tests and assays as specified in the USP compendia.
It is also used in the preparation of standard and system suitability solutions for the determination of organic impurities and performance tests of tablets and capsules, in accordance with the USP monographs, by liquid chromatography (LC) combined with UV detection, of the following:
  • Valsartan
  • Amlodipine and valsartan tablets
  • Valsartan and hydrochlorothiazide tablets
  • Amlodipine, valsartan, and hydrochlorothiazide tablets

In addition, it is used in the assay test of valsartan tablets by LC-UV following the USP monograph “Valsartan Tablets”.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

pictograms

Health hazardExclamation mark
GHS08,GHS07

signalword

Warning

Hazard Classifications

Repr. 2 - STOT SE 3

target_organs

Central nervous system

Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Valsartan and Hydrochlorothiazide Tablets
USP43-NF38: United States Pharmacopeia and National Formulary
United States Pharmacopeia, 37(4), 4580-4580 (2015)
Valsartan
USP43-NF38: United States Pharmacopeia and National Formulary
United States Pharmacopeia, 33(3), 4577-4577 (2020)
Tablet formulation and development of a validated stability indicating hplc method for quantification of valsartan and hydrochlorthiazide combination.
Kharoaf, M. A. H. E. R., et al.
International Journal of Pharmacy and Pharmaceutical Sciences, 4.3, 284-290 (2012)
Valsartan Tablets
USP43-NF38: United States Pharmacopeia and National Formulary
United States Pharmacopeia, 47(5), 4579-4579 (2017)
Amlodipine, Valsartan, and Hydrochlorothiazide Tablets
USP43-NF38: United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(2), 279-279 (2017)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service